HOME >> MEDICINE >> NEWS
Statins decrease risk of colon cancer

ANN ARBOR, Mich. -- People who took a type of cholesterol-lowering drug for five years had nearly half the risk of developing colon cancer, even when they had a family history of the disease or other risk factors, according to researchers at the University of Michigan Comprehensive Cancer Center.

Results of the study appear in the May 26 New England Journal of Medicine.

Statins, such as Zocor, Pravachol or Lipitor, are typically used for lowering cholesterol and have been shown to be effective at preventing cardiovascular disease.

"This is an important piece of the puzzle. This piece helps bring together evidence that statins may have the potential to prevent chronic diseases other than heart disease, and helps us consider ways to study these powerful drugs for more than one purpose," says study author Stephen Gruber, M.D., Ph.D., M.P.H., associate professor of internal medicine and human genetics at the U-M Medical School and associate professor of epidemiology at the U-M School of Public Health.

Data was based on the Molecular Epidemiology of Colorectal Cancer study, a population-based case-control study of colorectal cancer in northern Israel. The researchers analyzed 1,953 people with colorectal cancer and 2,015 control subjects who did not have colon cancer. All study participants were asked to recall every medication they had used for at least five years. Statin use was determined based on this list and validated against prescription records from the health care provider.

The people without colon cancer were nearly twice as likely to report taking statins for at least five years, compared to the people with a history of colon cancer, 11.6 percent vs. 6.1 percent.

Researchers analyzed the data taking into account increased or decreased risk associated with demographic factors such as age, sex and ethnic background, and with lifestyle factors such as taking aspirin, participating in sports and eating vegetables. T
'"/>


25-May-2005


Page: 1 2

Related medicine news :

1. Statins linked to lower risk of infection
2. Statins protect smokers from lung damage
3. Statins reduce risk of stroke in heart patients
4. Statins prove life-saving in patients with acute coronary syndromes
5. Statins may improve circulation in the retina
6. Statins, beta-blockers lessen heart attack risk, says Stanford-Kaiser study
7. Statins have neutral effect on risk of cancer
8. Statins may simulate stem cells for heart repair
9. Statins reduce the risk of stroke and death after carotid artery surgery
10. Statins use associated with lower risk of fractures
11. Statins protect from death from pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... Irving, Texas (PRWEB) , ... February 11, 2016 ... ... for plastic surgery, dermatology and women’s health, is pleased to announce the promotions ... Practice Development Partners sales team, Steve Catone to executive vice president of North ...
(Date:2/11/2016)... Washington, DC (PRWEB) , ... February 11, 2016 ... ... announce an upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study ... a not-for-profit Catholic health care system that’s partnering with Intel on value-based health ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... nominations seeking candidates for the Board of Commissioners. Individuals interested in volunteer board ... experience with diversity of clinical practice settings and across allied health to contribute ...
(Date:2/11/2016)... ... 2016 , ... PharmMD CEO Robert Yeager announced ... on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include ... data breaches for the Part D Star Rating improvement and Medication Therapy Management ...
(Date:2/11/2016)... Orange City, FL (PRWEB) , ... February 11, ... ... has announced the commencement of a master charity program created to assist the ... every 60 days, working closely with nonprofit organizations and community leaders. Their hope ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016  Proliant Biologicals is ... Bovine Serum Albumin (BSA) manufacturing facility.  The facility is ... Zealand , in Feilding. Boone ... done to functionally duplicate the systems in the U.S. ... vendors used for U.S. installations.  --> ...
(Date:2/11/2016)... February 11, 2016 Breast Cancer Therapeutics ... Asia-Pacific (APAC) breast cancer market will ... billion by 2021, at a Compound Annual Growth Rate (CAGR) ... Markets to 2021 - states that the ... expansion from $1.9 billion in 2014 to $3.4 billion by ...
(Date:2/11/2016)... NORTH CHICAGO, Ill. , Feb. 11, 2016 ... launch of the AbbVie Rheumatology Scholarship, designed to ... a rheumatologic disease as they pursue higher education ... $15,000 each for the 2016-2017 school year. The ... Tracie Haas , vice president, corporate ...
Breaking Medicine Technology:
Cached News: